Jinyun Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jinyun Tan has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Bo Yu
Department of Vascular Surgery Division, General Surgery Department, Huashan Hospital Affiliated to Fudan University
8 shared publications Weihao Shi
Department of Vascular Surgery Huashan Hospital Affiliated to Fudan University Shanghai China
7 shared publicationsLei Zhu
Department of Vascular Surgery, Huashan Hospital, Fudan University, Shanghai, 200040, China
6 shared publicationsQing He
Vascular Surgery Division, General Surgery Department, Huashan Hospital Affiliated to Fudan University, Shanghai, China (J. Tan, Q.H., W.G., K.L., W.S., B.Y.).
5 shared publications- Weijian Fan
Department of Vascular Surgery Huashan Hospital of Fudan University Shanghai P. R. China
5 shared publications Lei Zhang
National Engineering Research Center of Light Alloy Net Forming & State Key Laboratory of Metal Matrix Composite, School of Materials Science & Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China
4 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Elsevier in Materials Today Bio
- Vol. 41
Metal-based hydrogen-generating therapeutic systems: From reactive chemistry to route-specific exposure and translational design
- 22 October 2026
- Published by Elsevier in Materials Today Bio
- Vol. 41
Open AccessMetal-based hydrogen-generating therapeutic systems: From reactive chemistry to route-specific exposure and translational design
- 12 June 2026
- Published by Springer Nature in Nature Sensors
- Vol. 1 (7) , 636-648
Integrated thermal sensing of vascular morphology for haemodynamic monitoring
- 12 June 2026
- Published by Springer Nature in Nature Sensors
- Vol. 1 (7) , 636-648
Integrated thermal sensing of vascular morphology for haemodynamic monitoring
- Top Cited PapersOpen Access
- 15 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Wireless, non-invasive, high-resolution thrill sensor for continuous vascular access monitoring of hemodialysis patients
Hemodialysis is the primary life-sustaining therapy for patients with end-stage renal disease (ESRD). Diagnosing and monitoring the health condition of vascular access (VA) for hemodialysis involves the use of ultrasonic imaging and angiography. These infrequent tests cannot, however, identify signs of mild stenosis and sudden onset to facilitate early intervention. Hence, approximately 70% of hemodialysis patients experience VA failure each year, rendering dialysis difficult and posing life-threatening risks. Here, we report wireless, non-invasive thrill sensors incorporating high-resolution accelerometers designed to be conformally placed on VA skin for the continuous monitoring of VA thrill signals, which we tested in multi-platform validation including an in vitro benchtop system, canine models and patients (n = 9). Local measurements of VA thrill intensity via continuous wear demonstrated that a decrease in thrill intensity along the entire VA region is indicative of diminished VA function, while an abnormally heightened thrill intensity at a certain location along the VA indicates localized structural lesions. These thrill sensors may aid the early treatment of VA stenosis upon the transition from subjective thrill palpation to quantitative hemodynamic phenotyping.
- 15 March 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Top Cited PapersOpen AccessWireless, non-invasive, high-resolution thrill sensor for continuous vascular access monitoring of hemodialysis patients
Hemodialysis is the primary life-sustaining therapy for patients with end-stage renal disease (ESRD). Diagnosing and monitoring the health condition of vascular access (VA) for hemodialysis involves the use of ultrasonic imaging and angiography. These infrequent tests cannot, however, identify signs of mild stenosis and sudden onset to facilitate early intervention. Hence, approximately 70% of hemodialysis patients experience VA failure each year, rendering dialysis difficult and posing life-threatening risks. Here, we report wireless, non-invasive thrill sensors incorporating high-resolution accelerometers designed to be conformally placed on VA skin for the continuous monitoring of VA thrill signals, which we tested in multi-platform validation including an in vitro benchtop system, canine models and patients (n = 9). Local measurements of VA thrill intensity via continuous wear demonstrated that a decrease in thrill intensity along the entire VA region is indicative of diminished VA function, while an abnormally heightened thrill intensity at a certain location along the VA indicates localized structural lesions. These thrill sensors may aid the early treatment of VA stenosis upon the transition from subjective thrill palpation to quantitative hemodynamic phenotyping.
- 28 December 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (11) , e02482
Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury
Mitochondrial dysfunction and reactive oxygen species (ROS) overexpression are crucial factors inducing neuronal ferroptosis in cerebral ischemia/reperfusion injury (CIRI). Some therapeutics like RNAs and anti‐oxidation drugs have been developed to regulate the functions of mitochondria, but are hardly delivered into brain effectively due to the blood‐brain barrier (BBB). H 2 has recently been verified able to overcome the BBB efficiently and has a unique wide‐spectrum anti‐oxidation/anti‐inflammation effect, but sustainable, high‐amount, and safe delivery of H 2 into brain is still challenging currently. Herein, we develop an innovative H 2 administration method of intraperitoneal injection of magnesium hydride microparticles (MgH 2 ) with a high payload of hydrogen and a sustained hydrolytic H 2 production behavior, achieving persistent and high‐dose supply of H 2 into the blood system as well as in the brain. In addition, we establish a novel CIRI rabbit model induced by transcarotid artery revascularization (TCAR), which leads to oxidative stress and subsequent ferroptosis in the brain's hippocampus. In this CIRI model, MgH 2 treatment eliminates intracellular ROS, inhibits neuronal ferroptosis, and recovers mitochondrial dysfunction by stabilizing mitochondrial membrane potential, regulating mitobiogenesis, promoting neuronal energy metabolism, and activating the anti‐oxidative pathway. All these findings demonstrate that MgH 2 treatment provides a potential strategy for CIRI.
- 28 December 2025
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (11) , e02482
Constructing Mg‐Based Hydrogen Container for Mitochondrial Dysfunction and Neuronal Ferroptosis in TCAR‐Induced Cerebral Ischemia/Reperfusion Injury
Mitochondrial dysfunction and reactive oxygen species (ROS) overexpression are crucial factors inducing neuronal ferroptosis in cerebral ischemia/reperfusion injury (CIRI). Some therapeutics like RNAs and anti‐oxidation drugs have been developed to regulate the functions of mitochondria, but are hardly delivered into brain effectively due to the blood‐brain barrier (BBB). H 2 has recently been verified able to overcome the BBB efficiently and has a unique wide‐spectrum anti‐oxidation/anti‐inflammation effect, but sustainable, high‐amount, and safe delivery of H 2 into brain is still challenging currently. Herein, we develop an innovative H 2 administration method of intraperitoneal injection of magnesium hydride microparticles (MgH 2 ) with a high payload of hydrogen and a sustained hydrolytic H 2 production behavior, achieving persistent and high‐dose supply of H 2 into the blood system as well as in the brain. In addition, we establish a novel CIRI rabbit model induced by transcarotid artery revascularization (TCAR), which leads to oxidative stress and subsequent ferroptosis in the brain's hippocampus. In this CIRI model, MgH 2 treatment eliminates intracellular ROS, inhibits neuronal ferroptosis, and recovers mitochondrial dysfunction by stabilizing mitochondrial membrane potential, regulating mitobiogenesis, promoting neuronal energy metabolism, and activating the anti‐oxidative pathway. All these findings demonstrate that MgH 2 treatment provides a potential strategy for CIRI.
- Open Access
- 14 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Bioadhesive and conformable bioelectronic interfaces for vasomotoricity monitoring and regulation
The autonomic nervous system (ANS) dynamically regulates vasomotor function to maintain vascular homeostasis, yet current clinical tools lack the capacity to capture its electrophysiological basis, particularly following stent implantation. Herin, we report a bioadhesive and conformable bioelectronic (BACE) interface engineered for effective monitoring and modulation of vasomotoricity. Incorporating silk fibroin-based adhesives, the interface adheres robustly to cylindrical surfaces in aqueous conditions for up to two months. It exhibits low interfacial impedance (6.77 ± 2.13 kΩ at 1 kHz) and background noises (2.63 ± 0.52 μV) in vivo, enabling precise recording of varying vasomotor states. In a stent model, the interface identifies alterations in bioelectrical activity associated with vasomotor dysfunction, validated against ultrasound-derived arterial stiffness as clinical gold standards. Furthermore, we demonstrate a bidirectional system for the detection and modulation of dysfunction to restore vasomotor activity and elasticity. These findings provide insights into vasomotor electrophysiology mechanisms and underscore the therapeutic potential of bioelectronic modulation in vascular disease.
- 14 October 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-12
Open AccessBioadhesive and conformable bioelectronic interfaces for vasomotoricity monitoring and regulation
The autonomic nervous system (ANS) dynamically regulates vasomotor function to maintain vascular homeostasis, yet current clinical tools lack the capacity to capture its electrophysiological basis, particularly following stent implantation. Herin, we report a bioadhesive and conformable bioelectronic (BACE) interface engineered for effective monitoring and modulation of vasomotoricity. Incorporating silk fibroin-based adhesives, the interface adheres robustly to cylindrical surfaces in aqueous conditions for up to two months. It exhibits low interfacial impedance (6.77 ± 2.13 kΩ at 1 kHz) and background noises (2.63 ± 0.52 μV) in vivo, enabling precise recording of varying vasomotor states. In a stent model, the interface identifies alterations in bioelectrical activity associated with vasomotor dysfunction, validated against ultrasound-derived arterial stiffness as clinical gold standards. Furthermore, we demonstrate a bidirectional system for the detection and modulation of dysfunction to restore vasomotor activity and elasticity. These findings provide insights into vasomotor electrophysiology mechanisms and underscore the therapeutic potential of bioelectronic modulation in vascular disease.
- Open Access
IL-17A-driven Macrophage Disorder Promotes Plaque Instability in Psoriatic Atherosclerosis
Psoriasis is a common chronic inflammatory skin disease that predisposes individuals to cardiovascular diseases such as atherosclerosis. However, the underlying mechanisms linking these conditions have not yet been fully elucidated. Recent studies have indicated that the inflammatory cytokine IL-17A plays a significant role in both diseases. The aim of this study was to investigate how psoriasis affects the stability of atherosclerotic plaques via the IL-17A/IL-17RA pathway. We performed single-cell sequencing on patients with both psoriasis and atherosclerosis to analyze changes in the immune microenvironment within their carotid plaques and psoriatic lesions. We found that IL-17A significantly upregulated the expression of pro-inflammatory factors (e.g., CXCL8) in macrophages of psoriatic atherosclerosis patients, leading to weakening of the fibrous cap structure of plaques. Additionally, IL-17A further exacerbated plaque instability by interfering with macrophage lipid metabolism, particularly sphingolipid metabolism. Finally, using in vitro experiments and animal models, we demonstrated that IL-17A enhances pro-inflammatory and metabolic abnormalities in macrophages by downregulating PPARγ. Therapeutic strategies targeting IL-17A may contribute to the simultaneous mitigation of psoriasis and atherosclerosis-associated cardiovascular risk, providing new directions for clinical intervention.
Open AccessIL-17A-driven Macrophage Disorder Promotes Plaque Instability in Psoriatic Atherosclerosis
Psoriasis is a common chronic inflammatory skin disease that predisposes individuals to cardiovascular diseases such as atherosclerosis. However, the underlying mechanisms linking these conditions have not yet been fully elucidated. Recent studies have indicated that the inflammatory cytokine IL-17A plays a significant role in both diseases. The aim of this study was to investigate how psoriasis affects the stability of atherosclerotic plaques via the IL-17A/IL-17RA pathway. We performed single-cell sequencing on patients with both psoriasis and atherosclerosis to analyze changes in the immune microenvironment within their carotid plaques and psoriatic lesions. We found that IL-17A significantly upregulated the expression of pro-inflammatory factors (e.g., CXCL8) in macrophages of psoriatic atherosclerosis patients, leading to weakening of the fibrous cap structure of plaques. Additionally, IL-17A further exacerbated plaque instability by interfering with macrophage lipid metabolism, particularly sphingolipid metabolism. Finally, using in vitro experiments and animal models, we demonstrated that IL-17A enhances pro-inflammatory and metabolic abnormalities in macrophages by downregulating PPARγ. Therapeutic strategies targeting IL-17A may contribute to the simultaneous mitigation of psoriasis and atherosclerosis-associated cardiovascular risk, providing new directions for clinical intervention.
- Open Access
- 5 March 2025
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 10 (6) , 702-714
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury
Background: Cerebral ischemia-reperfusion injury (CIRI) leads to cognitive dysfunction, neuronal death, and inflammation. Understanding the molecular mechanisms underlying CIRI is crucial for developing effective therapeutic strategies. Objective: This study aims to investigate the roles of activating transcription factor 3 (Atf3) and lon protease homolog 1 (Lonp1) in CIRI, particularly focusing on how Atf3 regulates Lonp1 expression and its effects on mitochondrial function. Methods: Single-cell transcriptomics and proteomic analyses were employed to explore Atf3's influence on Lonp1 and its subsequent impact on neuronal survival and apoptosis. Results: The findings indicate that Atf3 plays a crucial role in modulating Lonp1 expression, which in turn affects mitochondrial function, neuronal survival, and apoptotic pathways. Conclusion: This study provides new insights into the regulatory mechanisms of Atf3 and Lonp1 in CIRI, identifying potential therapeutic targets for managing ischemic brain injury and neurodegenerative diseases.
- 5 March 2025
- Published by BMJ in Stroke and Vascular Neurology
- Vol. 10 (6) , 702-714
Open AccessDual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury
Background: Cerebral ischemia-reperfusion injury (CIRI) leads to cognitive dysfunction, neuronal death, and inflammation. Understanding the molecular mechanisms underlying CIRI is crucial for developing effective therapeutic strategies. Objective: This study aims to investigate the roles of activating transcription factor 3 (Atf3) and lon protease homolog 1 (Lonp1) in CIRI, particularly focusing on how Atf3 regulates Lonp1 expression and its effects on mitochondrial function. Methods: Single-cell transcriptomics and proteomic analyses were employed to explore Atf3's influence on Lonp1 and its subsequent impact on neuronal survival and apoptosis. Results: The findings indicate that Atf3 plays a crucial role in modulating Lonp1 expression, which in turn affects mitochondrial function, neuronal survival, and apoptotic pathways. Conclusion: This study provides new insights into the regulatory mechanisms of Atf3 and Lonp1 in CIRI, identifying potential therapeutic targets for managing ischemic brain injury and neurodegenerative diseases.
- Open Access
- 2 October 2024
- Published by Springer Nature in npj Flexible Electronics
- Vol. 8 (1) , 1-14
Self-adaptive epidermal blood flow sensor for high-flux vascular access monitoring of hemodialysis patients
- 2 October 2024
- Published by Springer Nature in npj Flexible Electronics
- Vol. 8 (1) , 1-14
Open AccessSelf-adaptive epidermal blood flow sensor for high-flux vascular access monitoring of hemodialysis patients
- Open Access
Antiferroptosis therapy alleviated the development of atherosclerosis
Ferroptosis has been confirmed to be associated with various diseases, but the relationship between ferroptosis and atherosclerosis (AS) remains unclear. Our research detailly clarified the roles of ferroptosis in three continuous and main pathological stages of AS respectively (injury of endothelial cells [ECs], adhesion of monocytes, and formation of foam cells). We confirmed that oxidized low‐density lipoprotein (ox‐LDL), the key factor in the pathogenesis of AS, strongly induced ferroptosis in ECs. Inhibition of ferroptosis repressed the adhesion of monocytes to ECs by inhibiting inflammation of ECs. Ferroptosis also participated in the formation of foam cells and lipids by regulating the cholesterol efflux of macrophages. Further research confirmed that ox‐LDL repressedthe activity of glutathione peroxidase 4 (GPX4), the classic lipid peroxide scavenger. Treatment of a high‐fat diet significantly induced ferroptosis in murine aortas and aortic sinuses, which was accompanied by AS lesions and hyperlipidemia. Treatment with ferroptosis inhibitors significantly reduced ferroptosis, hyperlipidemia, and AS lesion development. In conclusion, our research determined that ox‐LDL induced ferroptosis by repressing the activity of GPX4. Antiferroptosis treatment showed promising treatment effects in vivo. Ferroptosis‐associated indexes also showed promising diagnostic potential in AS patients.
Open AccessAntiferroptosis therapy alleviated the development of atherosclerosis
Ferroptosis has been confirmed to be associated with various diseases, but the relationship between ferroptosis and atherosclerosis (AS) remains unclear. Our research detailly clarified the roles of ferroptosis in three continuous and main pathological stages of AS respectively (injury of endothelial cells [ECs], adhesion of monocytes, and formation of foam cells). We confirmed that oxidized low‐density lipoprotein (ox‐LDL), the key factor in the pathogenesis of AS, strongly induced ferroptosis in ECs. Inhibition of ferroptosis repressed the adhesion of monocytes to ECs by inhibiting inflammation of ECs. Ferroptosis also participated in the formation of foam cells and lipids by regulating the cholesterol efflux of macrophages. Further research confirmed that ox‐LDL repressedthe activity of glutathione peroxidase 4 (GPX4), the classic lipid peroxide scavenger. Treatment of a high‐fat diet significantly induced ferroptosis in murine aortas and aortic sinuses, which was accompanied by AS lesions and hyperlipidemia. Treatment with ferroptosis inhibitors significantly reduced ferroptosis, hyperlipidemia, and AS lesion development. In conclusion, our research determined that ox‐LDL induced ferroptosis by repressing the activity of GPX4. Antiferroptosis treatment showed promising treatment effects in vivo. Ferroptosis‐associated indexes also showed promising diagnostic potential in AS patients.
- Open Access
- 1 December 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (12) , 2312-2332
Single-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events
BACKGROUND: Carotid atherosclerosis is a chronic inflammatory disorder and is responsible for the vast majority of ischemic strokes. Inappropriate innate and adaptive immune responses synergize with malfunctional vascular wall cells to cause atherosclerotic lesions. Yet, functional characteristics of specific immune and endothelial cell subsets associated with atherosclerosis and cerebrovascular events are poorly understood. METHODS: Here, using single-cell RNA sequencing, the unprecedentedly largest data set from 20 patients’ carotid artery plaques and paired peripheral blood mononuclear cells was generated, with which an ultra-high-precision cellular landscape of the atherosclerotic microenvironment involving 372 070 cells was depicted. RESULTS: Compared with peripheral blood mononuclear cells, 3 plaque-specific T-cell subsets exhibiting proatherogenic features of both activation and exhaustion were identified. Strikingly, usually antiatherogenic, CD4 + FOXP3 + regulatory T cells from plaques of patients with symptomatic disease acquired proinflammatory properties by probably converting to T helper 17 and T helper 9 cells, while CD4 + NR4A1 + /C0 and CD8 + SLC4A10 + T cells related to cerebrovascular events possessed atherogenic attributes including proinflammation, polarization, and exhaustion. In addition, monocyte-macrophage dynamics dominated innate immune response. Two plaque-specific monocyte subsets performed diametrically opposed functions, EREG + monocytes promoted cerebrovascular events while C3 + monocytes are anti-inflammatory. Similarly, IGF1 + and HS3ST2 + macrophages with classical proinflammatory M1 macrophage features were annotated and contributed to cerebrovascular events. Moreover, SULF1 + (sulfatase-1) endothelial cells were also found to participate in cerebrovascular events through affecting plaque vulnerability. CONCLUSIONS: This compendium of single-cell transcriptome data provides valuable insights into the cellular heterogeneity of the atherosclerotic microenvironment and the development of more precise cardiovascular immunotherapies.
- 1 December 2023
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 43 (12) , 2312-2332
Open AccessSingle-Cell Transcriptomics Reveals Crucial Cell Subsets and Functional Heterogeneity Associated With Carotid Atherosclerosis and Cerebrovascular Events
BACKGROUND: Carotid atherosclerosis is a chronic inflammatory disorder and is responsible for the vast majority of ischemic strokes. Inappropriate innate and adaptive immune responses synergize with malfunctional vascular wall cells to cause atherosclerotic lesions. Yet, functional characteristics of specific immune and endothelial cell subsets associated with atherosclerosis and cerebrovascular events are poorly understood. METHODS: Here, using single-cell RNA sequencing, the unprecedentedly largest data set from 20 patients’ carotid artery plaques and paired peripheral blood mononuclear cells was generated, with which an ultra-high-precision cellular landscape of the atherosclerotic microenvironment involving 372 070 cells was depicted. RESULTS: Compared with peripheral blood mononuclear cells, 3 plaque-specific T-cell subsets exhibiting proatherogenic features of both activation and exhaustion were identified. Strikingly, usually antiatherogenic, CD4 + FOXP3 + regulatory T cells from plaques of patients with symptomatic disease acquired proinflammatory properties by probably converting to T helper 17 and T helper 9 cells, while CD4 + NR4A1 + /C0 and CD8 + SLC4A10 + T cells related to cerebrovascular events possessed atherogenic attributes including proinflammation, polarization, and exhaustion. In addition, monocyte-macrophage dynamics dominated innate immune response. Two plaque-specific monocyte subsets performed diametrically opposed functions, EREG + monocytes promoted cerebrovascular events while C3 + monocytes are anti-inflammatory. Similarly, IGF1 + and HS3ST2 + macrophages with classical proinflammatory M1 macrophage features were annotated and contributed to cerebrovascular events. Moreover, SULF1 + (sulfatase-1) endothelial cells were also found to participate in cerebrovascular events through affecting plaque vulnerability. CONCLUSIONS: This compendium of single-cell transcriptome data provides valuable insights into the cellular heterogeneity of the atherosclerotic microenvironment and the development of more precise cardiovascular immunotherapies.